List view / Grid view
The number of oligonucleotide-based platforms on the market is constantly increasing and has led to the emergence of innovative nucleic acid-based therapeutic modalities such as CRISPR-Cas, sgRNAs or mRNAs.
The articles in this antibodies In-Depth Focus assess the methods used to develop antibody therapeutics and the evolution of this area of medicine to identify drug targets.
New lab on a chip technology has been developed to evaluate the effects of different drivers of NAFLD on liver cells.
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
A unique method for studying proteins has been developed which could open new doors for medicinal research.
13 June 2019 | By Sartorius AG
The new generation of modular premium laboratory balances.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
A new report reveals a thriving service and supply sector for the UK in addition to its research and development biotechs.
The global gene editing tools market is estimated to have accounted for more than US$258 million in terms of value in 2018.
Typically, early drug discovery campaigns start with the screening of chemical libraries to identify candidate chemotypes modulating a particular target and/or phenotype. Success of the primary screening depends on multiple factors related to both biology and chemistry. These include the target’s druggability, sensitivity and specificity of assay system, composition and…
Researchers have developed a new technology that allows them to probe cell changes without disturbing the cell’s physiology.
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumour or another disease site.
Researchers have indicated that the accumulation of pathological tau triggers a safety valve mechanism in the otherwise well-regulated cell membranes...
